Breaking Biotech
By Matthew Lepoire
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Matthew Lepoire
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 30
Reviews: 0
Episodes: 10
Description
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
| Episode | Date |
|---|---|
|
113 - Vaxxinity Takes on Neurodegenerative Diseases with Vaccines - Potential Short Opportunity?
|
May 08, 2022 |
|
112 - Biotech Updates - $BTAI $TGTX $CRIS $CKPT $KPTI $SRRA
|
Apr 21, 2022 |
|
111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich
|
Apr 01, 2022 |
|
110 - Kodiac Sciences FALLS on Negative Wet AMD Readout! Buying Opportunity or Falling Knife??
|
Mar 05, 2022 |
|
109 - Karyopharm Guides INCREASED Sales Growth in 2022 and Reports Positive SIENDO Results
|
Feb 22, 2022 |
|
108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD
|
Feb 07, 2022 |
|
107 - CymaBay Sets to Massively Improve Outcomes in PBC Patients | Interview with CEO Sujal Shah
|
Jan 29, 2022 |
|
106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch!
|
Jan 09, 2022 |
|
105 - Neurodegenerative Disease Recap! ALXO and LGVN updates plus Breaking Breaking 2021 Top Trades
|
Jan 03, 2022 |
|
104 - Biotech Bear Market Offers SIGNIFICANT Opportunity in Oncology - CRIS! Longeveron Rises on ODD
|
Dec 12, 2021 |